# Anixa Biosciences Inc: Form 8-K, filed Dec 9, 2021

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: 8-K
- Filed: 2021-12-09
- Accepted by EDGAR: Dec 9, 2021, 16:15 ET
- Period: 2021-12-07
- Accession: 0001493152-21-030965
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315221030965/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315221030965/

## Items reported

- Item 5.08: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315221030965/form8-k.htm

Filed Dec 9, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-030965. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.